mecwins. Innovation in nanomechanics for biotechbology

4th International Conference on Bio-Sensing Technology

Following the success of the first 3 conferences, the 4th International Conference on Bio-Sensing Technology will continue to bring together leaders from industry and academia to exchange and share their experiences, present research results, explore collaborations and to spark new ideas, with the aim of developing new projects and exploiting new technology for bio-sensing applications. 

The conference will take place at the Sheraton Lisboa Hotel, located in one of Lisbon’s most privileged business areas from 10 to 13th of May. 

Our abstract entitled “SCALA as a characterization tool for the nanomechanical detection of biomarkers in human whole blood” has been accepted for poster presentation at the Conference. In our study, SCALA has been used for the successful detection of the cardiac biomarker Troponin I (Tn I, the gold standard myocardial infarction biomarker) directly in human whole blood samples.

Troponin Experiment  

In the figure above, we show the nanomechanical (a.) and plasmonic (b.) detection of the biomarker Tn I in human whole blood samples: silicon cantilever before and after incubation with blood and detection antibodies tethered to the gold-nanoparticles.

These promising results open new capabilities for biosensing protocols in human whole blood samples.



01 MECWINS 01 from Montserrat Calleja on Vimeo.


Mecwins is a newly established technological company with a strong focus on R&D. Our activity is highly driven by cutting-edge technology and frontline innovation. CIALIS 

Mecwins is developing Nanotechnologies to an advanced stage where they can be applied to diversified fields, from NEMS characterization to clinical analysis.

We use cookies of our own and of third parties to improve our services and to be able to offer you, by means of web browsing analysis, the best options.
If you continue browsing, we assume that you agree to their use. For further information, please click here.
Enterprise Platform